198 related articles for article (PubMed ID: 26656689)
1. Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors.
Wang F; Chen C; Liu X; Yang K; Xu X; Yang H
J Virol; 2016 Feb; 90(4):1910-7. PubMed ID: 26656689
[TBL] [Abstract][Full Text] [Related]
2. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
[TBL] [Abstract][Full Text] [Related]
3. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
[TBL] [Abstract][Full Text] [Related]
4. Crystallization and preliminary crystallographic study of Feline infectious peritonitis virus main protease in complex with an inhibitor.
Wang J; Wang F; Tan Y; Chen X; Zhao Q; Fu S; Li S; Chen C; Yang H
Acta Crystallogr F Struct Biol Commun; 2014 Dec; 70(Pt 12):1612-5. PubMed ID: 25484209
[TBL] [Abstract][Full Text] [Related]
5. Adaptive Mutation in the Main Protease Cleavage Site of Feline Coronavirus Renders the Virus More Resistant to Main Protease Inhibitors.
Jiao Z; Yan Y; Chen Y; Wang G; Wang X; Li L; Yang M; Hu X; Guo Y; Shi Y; Peng G
J Virol; 2022 Sep; 96(17):e0090722. PubMed ID: 36000844
[TBL] [Abstract][Full Text] [Related]
6. X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design.
St John SE; Therkelsen MD; Nyalapatla PR; Osswald HL; Ghosh AK; Mesecar AD
Bioorg Med Chem Lett; 2015 Nov; 25(22):5072-7. PubMed ID: 26592814
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease.
Kim Y; Mandadapu SR; Groutas WC; Chang KO
Antiviral Res; 2013 Feb; 97(2):161-8. PubMed ID: 23219425
[TBL] [Abstract][Full Text] [Related]
8. Crystallization of Feline Coronavirus M
Lu J; Chen SA; Khan MB; Brassard R; Arutyunova E; Lamer T; Vuong W; Fischer C; Young HS; Vederas JC; Lemieux MJ
Front Chem; 2022; 10():852210. PubMed ID: 35281564
[TBL] [Abstract][Full Text] [Related]
9. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication.
Vuong W; Khan MB; Fischer C; Arutyunova E; Lamer T; Shields J; Saffran HA; McKay RT; van Belkum MJ; Joyce MA; Young HS; Tyrrell DL; Vederas JC; Lemieux MJ
Nat Commun; 2020 Aug; 11(1):4282. PubMed ID: 32855413
[TBL] [Abstract][Full Text] [Related]
10. Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design.
Wang F; Chen C; Tan W; Yang K; Yang H
Sci Rep; 2016 Mar; 6():22677. PubMed ID: 26948040
[TBL] [Abstract][Full Text] [Related]
11. In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus.
Theerawatanasirikul S; Kuo CJ; Phetcharat N; Lekcharoensuk P
Antiviral Res; 2020 Feb; 174():104697. PubMed ID: 31863793
[TBL] [Abstract][Full Text] [Related]
12. Feline infectious peritonitis: insights into feline coronavirus pathobiogenesis and epidemiology based on genetic analysis of the viral 3c gene.
Chang HW; de Groot RJ; Egberink HF; Rottier PJ
J Gen Virol; 2010 Feb; 91(Pt 2):415-20. PubMed ID: 19889934
[TBL] [Abstract][Full Text] [Related]
13. Structures of the Middle East respiratory syndrome coronavirus 3C-like protease reveal insights into substrate specificity.
Needle D; Lountos GT; Waugh DS
Acta Crystallogr D Biol Crystallogr; 2015 May; 71(Pt 5):1102-11. PubMed ID: 25945576
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of the active centre of coronavirus 3C-like proteases.
Hegyi A; Friebe A; Gorbalenya AE; Ziebuhr J
J Gen Virol; 2002 Mar; 83(Pt 3):581-593. PubMed ID: 11842253
[TBL] [Abstract][Full Text] [Related]
15. Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.
Kim Y; Liu H; Galasiti Kankanamalage AC; Weerasekara S; Hua DH; Groutas WC; Chang KO; Pedersen NC
PLoS Pathog; 2016 Mar; 12(3):e1005531. PubMed ID: 27027316
[TBL] [Abstract][Full Text] [Related]
16. Recent progress in the discovery of inhibitors targeting coronavirus proteases.
Wang H; Xue S; Yang H; Chen C
Virol Sin; 2016 Feb; 31(1):24-30. PubMed ID: 26920707
[TBL] [Abstract][Full Text] [Related]
17. Drug design targeting the main protease, the Achilles' heel of coronaviruses.
Yang H; Bartlam M; Rao Z
Curr Pharm Des; 2006; 12(35):4573-90. PubMed ID: 17168763
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.
Wang YC; Yang WH; Yang CS; Hou MH; Tsai CL; Chou YZ; Hung MC; Chen Y
Am J Cancer Res; 2020; 10(8):2535-2545. PubMed ID: 32905393
[TBL] [Abstract][Full Text] [Related]
19. ATP1A1-mediated Src signaling inhibits coronavirus entry into host cells.
Burkard C; Verheije MH; Haagmans BL; van Kuppeveld FJ; Rottier PJ; Bosch BJ; de Haan CA
J Virol; 2015 Apr; 89(8):4434-48. PubMed ID: 25653449
[TBL] [Abstract][Full Text] [Related]
20. Structural Basis of the Main Proteases of Coronavirus Bound to Drug Candidate PF-07321332.
Li J; Lin C; Zhou X; Zhong F; Zeng P; Yang Y; Zhang Y; Yu B; Fan X; McCormick PJ; Fu R; Fu Y; Jiang H; Zhang J
J Virol; 2022 Apr; 96(8):e0201321. PubMed ID: 35389231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
